You are currently viewing a new version of our website. To view the old version click .

Therapeutic Significance of Heme Oxygenase Induction or Inhibition

This special issue belongs to the section “Molecular Medicine“.

Special Issue Information

Dear colleagues,

A heme oxygenase (HO) system consists of two different isoforms, HO-1, the inducible form, and HO-2, the constitutive form. Both isozymes catalyze the rate-limiting step in heme degradation, resulting in the formation of biliverdin with the concurrent release of carbon monoxide (CO) and iron. HO-1 induction by drugs, polyphenols, and a variety of stimuli, such as low-grade inflammation and oxidative stress, is mediated by the nuclear factor erythroid 2-related factor 2 (Nrf2). HO plays a key role as a cytoprotective system and as an endogenous antioxidant system by scavenging reactive oxygen species (ROS) and preventing apoptosis during stress conditions. However, recently, it has been shown that a HO system may possess important biological functions beyond its enzymatic activity. The up-regulation of HO-1 and its cellular localization could presumably reduce the efficacy of chemotherapeutic agents in the treatment of several cancers.

Prof. Luca Vanella
Dr. Marco Raffaele
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • HO-1
  • HO-2
  • antioxidants
  • apoptosis
  • cancer
  • Nrf2
  • heme oxygenase inducers
  • heme oxygenase inhibitors
  • carbon monoxide
  • biliverdin

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Biomolecules - ISSN 2218-273X